Exploration of Social and Political Factors that Impede Migrant Healthcare Availability and Access in Canada Amidst COVID-19

by Anish Arora, Alayne Adams, Bertrand Lebouché, Amélie Quesnel-Vallée
Published 2021-04-01

Explaining the Presence of “Heterosexual” Female Clients of a Rapid HIV Testing Site Located in the Gay Village of Montreal, Quebec

by Kim Engler, Kathleen Rollet, David Lessard, Réjean Thomas, Bertrand Lebouché
Published 2016-04-01

A review of HIV-specific patient-reported measures of perceived barriers to antiretroviral therapy adherence: what themes are they covering?

by Kim Engler, Isabelle Toupin, Serge Vicente, Sara Ahmed, Bertrand Lebouché
Published 2019-06-01

A type II implementation-effectiveness hybrid quasi-experimental pilot study of a clinical intervention to re-engage people living with HIV into care, ‘Lost & Found’: an implementa...

by Joseph Cox, Blake Linthwaite, Kim Engler, David Lessard, Bertrand Lebouché, Nadine Kronfli
Published 2020-02-01

Evaluation of a Rapid Point of Care Test for Detecting Acute and Established HIV Infection, and Examining the Role of Study Quality on Diagnostic Accuracy: A Bayesian Meta-Analysis...

by Megan Smallwood, Rohit Vijh, Bénédicte Nauche, Bertrand Lebouché, Lawrence Joseph, Nitika Pant Pai
Published 2016-01-01

HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

by Rujun Song, Irene Lisovsky, Bertrand Lebouché, Jean-Pierre Routy, Julie Bruneau, Nicole F Bernard
Published 2014-01-01

Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4+ T Cells

by Alexandra Tremblay-McLean, Julie Bruneau, Bertrand Lebouché, Irene Lisovsky, Rujun Song, Nicole F. Bernard
Published 2017-10-01

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.

by Gamze Isitman, Alexandra Tremblay-McLean, Irene Lisovsky, Julie Bruneau, Bertrand Lebouché, Jean-Pierre Routy, Nicole F Bernard
Published 2016-01-01

Barriers and facilitators associated with steps of the HIV care cascade for migrants in OECD countries: a systematic mixed studies review protocol

by Bertrand Lebouché, Isabelle Vedel, Anish Arora, Amelie Quesnel-Vallee, David Lessard, Kedar Mate, Adriana Rodriguez-Cruz, Nadine Kronfli, Kim Engler
Published 2020-11-01

HIV-Positive Patients’ Perceptions of Antiretroviral Therapy Adherence in Relation to Subjective Time: Imprinting, Domino Effects, and Future Shadowing

by David Lessard PhD, Isabelle Toupin PhD, Kim Engler PhD, Andràs Lènàrt MSc c, Bertrand Lebouché MD, PhD
Published 2018-02-01

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.

by Amine Benmassaoud, Peter Ghali, Joseph Cox, Philip Wong, Jason Szabo, Marc Deschenes, Maria Osikowicz, Bertrand Lebouche, Marina B Klein, Giada Sebastiani
Published 2018-01-01

Influence of microbial translocation and inflammation on CD8 T-cell elevation in primary HIV-1 infection

by Vikram Mehraj, Mohammad-Ali Jenabian, Rosalie Ponte, Bertrand Lebouché, Réjean Thomas, Jean-Guy Baril, Roger Leblanc, Cécile Tremblay, Jean-Pierre Routy
Published 2016-05-01

Delayed linkage to HIV care among asylum seekers in Quebec, Canada

by Nadine Kronfli, Blake Linthwaite, Nancy Sheehan, Joseph Cox, Isabelle Hardy, Bertrand Lebouché, Alexandra de Pokomandy, Charles Frenette, Michel Roger, Marina B. Klein
Published 2019-12-01

Challenges of Patient Engagement in an HIV Clinical Research Program: A Qualitative Analysis of Stakeholder Accounts

by David Lessard PhD, Kim Engler PhD, Serge Vicente PhD, Martin Bilodeau MD, PhD, Bertrand Lebouché MD, PhD
Published 2020-12-01

Clinical and socio-demographic characteristics and early ART initiation during primary HIV infection

by Vikram Mehraj, Wei Cao, Rosalie Ponte, Mario Legault, Bertrand Lebouché, Réjean Thomas, Jean-Guy Baril, Roger Leblanc, Cécile Tremblay, Jean-Pierre Routy
Published 2016-05-01

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

by Vikram Mehraj, Vikram Mehraj, Vikram Mehraj, Rayoun Ramendra, Rayoun Ramendra, Rayoun Ramendra, Stéphane Isnard, Stéphane Isnard, Franck P. Dupuy, Franck P. Dupuy, Bertrand Lebouché, Bertrand Lebouché, Bertrand Lebouché, Cecilia Costiniuk, Cecilia Costiniuk, Réjean Thomas, Jason Szabo, Jason Szabo, Jean-Guy Baril, Benoit Trottier, Pierre Coté, Roger LeBlanc, Madéleine Durand, Carl Chartrand-Lefebvre, Ido Kema, Yonglong Zhang, Malcolm Finkelman, Cécile Tremblay, Cécile Tremblay, Jean-Pierre Routy, Jean-Pierre Routy, Jean-Pierre Routy
Published 2019-02-01

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects

by Franck P. Dupuy, Sanket Kant, Alexandre Barbé, Jean-Pierre Routy, Julie Bruneau, Bertrand Lebouché, Cécile Tremblay, Marzena Pazgier, Andrés Finzi, Nicole F. Bernard
Published 2019-12-01

Soluble ST2 rings the alarm for gut damage and immune activation in primary HIV infection

by Vikram Mehraj, Mohammad-Ali Jenabian, Rosalie Ponte, Bertrand Lebouché, Cecilia Costiniuk, Réjean Thomas, Jean-Guy Baril, Roger Leblanc, Joseph Cox, Cécile Tremblay, Jean-Pierre Routy
Published 2016-05-01

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research

by Vikram Mehraj, Peter Ghali, Rayoun Ramendra, Cecilia Costiniuk, Bertrand Lebouché, Rosalie Ponte, Robert Reinhard, Jose Sousa, Nicolas Chomont, Eric A. Cohen, Petronela Ancuta, Jean-Pierre Routy
Published 2017-10-01

15 Pulmonary T cells and HIV reservoirs in adults under suppressive ART

by CeciliaT Costiniuk, Omar Farnos, Syim Salahuddin, Ron Olivenstein, Jean-Pierre Routy, Amélie Pagliuzza, Christina Castro, de, Jean Bourbeau, Bertrand Lebouché, Petronela Ancuta, Nicolas Chomont, Mohammad-Ali Jenabian
Published 2017-07-01